Table 2.
Content and organization comparison between neonatal formularies: General characteristics.
| Parameter | Neofax | ANMF | DPF | NNF | Pediatric and Neonatal Lexi-Drugs | BNF for Children |
|---|---|---|---|---|---|---|
| Pediatric and Neonatal formulary or neonatal only | Neonatal only (a parallel module is available for pediatric patients) | Neonatal | Neonatal and pediatric | Neonatal and pediatric (infancy) | Neonatal and pediatric | Neonatal and pediatric |
| Number of drug monographs included overall | 304 (pediatric: 804) |
182 | 884 | 265 (covering over 300 unique drugs or drug combinations) | 1460 (376 with neonatal dosing) | 1031 |
| Number of monographs with DI for term neonates | 304 | 182 | 252 | N/A | 360 | 218 |
| Number of monographs with DI for preterm neonates | 112 | 182 | 73 | N/A | 336 | N/A |
| Are references and citations included? | Yes, in-line and collectively under a ‘References’ section | Yes, in-line and collectively under a ‘References’ section | Yes, in-line and collectively under a ‘References’ section | Yes, collectively in the end of the monograph | Yes, in-line and collectively under a ‘References’ section | No |
| Is communication between users and authors possible? | Yes | Yes | Yes, contact form “suggestions for improvement” is included in each monograph, delivered to editorial team |
Yes (through email to publishers) | Yes, via online customer support | Yes, clinical content enquiries can be made via email |
| Peer-reviewed | Yes | Yes | Yes | Yes | Yes | Yes |
| Funded by public/not for profit or private/commercial | Commercial | Public/not for profit | Public/not for profit | Commercial | Commercial | Commercial |
| Independent from pharmaceutical industry | Yes | Yes | Yes | Yes | Yes | Yes |
| Are commercial products listed? | Yes (available formulations and strengths) | Yes | Yes (available formulations and strengths are listed) | Yes | Yes, in Brand Names sections for US, Canada and International (where appropriate) | Yes |
N/A = Not available.